Digestive & Intestinal Remedies (Pharmacies) - Egypt

  • Egypt
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$173.90m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.84%, resulting in a market volume of US$253.60m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.52 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Egypt is experiencing steady growth due to several factors. Customer preferences are shifting towards natural and herbal remedies, while trends in the market indicate an increasing demand for digestive health products. Local special circumstances, such as a growing middle class and an aging population, contribute to the market's development. Additionally, underlying macroeconomic factors, such as increasing disposable income and a focus on healthcare, further drive the growth of the Digestive & Intestinal Remedies market in Egypt. Customer preferences in Egypt are changing, with a growing interest in natural and herbal remedies for digestive health issues. Consumers are becoming more conscious about the ingredients in the products they use and are seeking alternatives to traditional pharmaceutical options. This shift in preferences is driven by a desire for more holistic and natural approaches to healthcare. As a result, there is an increasing demand for digestive health products that are made from natural ingredients and have fewer side effects. Trends in the Digestive & Intestinal Remedies market in Egypt indicate a growing demand for products that promote digestive health. This can be attributed to several factors. Firstly, there is a rise in the prevalence of digestive disorders, such as indigestion, bloating, and acid reflux, which has led to an increased demand for remedies that can provide relief. Secondly, there is a growing awareness among consumers about the importance of maintaining a healthy digestive system, which has led to a greater emphasis on preventive measures and the use of digestive health products. Local special circumstances in Egypt contribute to the development of the Digestive & Intestinal Remedies market. The country has a growing middle class, which has led to an increase in disposable income and a higher spending capacity. This allows consumers to afford healthcare products and invest in their well-being. Additionally, Egypt has an aging population, which is more prone to digestive health issues. As a result, there is a higher demand for remedies that can address these concerns and improve overall digestive health. Underlying macroeconomic factors also play a role in the growth of the Digestive & Intestinal Remedies market in Egypt. The country has been experiencing economic growth, which has led to an increase in disposable income. This allows consumers to allocate more of their budget towards healthcare and wellness products, including digestive remedies. Furthermore, there is a growing focus on healthcare in Egypt, with the government investing in the sector and promoting awareness about the importance of preventive healthcare. This has created a favorable environment for the growth of the Digestive & Intestinal Remedies market. In conclusion, the Digestive & Intestinal Remedies market in Egypt is developing due to changing customer preferences, increasing demand for digestive health products, local special circumstances such as a growing middle class and an aging population, and underlying macroeconomic factors such as increasing disposable income and a focus on healthcare. These factors contribute to the steady growth of the market and present opportunities for both local and international companies operating in the Digestive & Intestinal Remedies sector in Egypt.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)